[
  {
    "ts": null,
    "headline": "Baxter International: Transition Year With No Immediate Catalysts",
    "summary": "Baxter (BAX) stock: deep 30â50% valuation discount but limited catalysts as CEO focuses on cuts and deleveraging; learn key risks & upside by 2026âread now.",
    "url": "https://finnhub.io/api/news?id=4d93bdc6e00650bab522ac0c84c6c58d55ac29a00fdac9e0d0183f3f3fb1928e",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768914342,
      "headline": "Baxter International: Transition Year With No Immediate Catalysts",
      "id": 138188798,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2224035486/image_2224035486.jpg?io=getty-c-w1536",
      "related": "BAX",
      "source": "SeekingAlpha",
      "summary": "Baxter (BAX) stock: deep 30â50% valuation discount but limited catalysts as CEO focuses on cuts and deleveraging; learn key risks & upside by 2026âread now.",
      "url": "https://finnhub.io/api/news?id=4d93bdc6e00650bab522ac0c84c6c58d55ac29a00fdac9e0d0183f3f3fb1928e"
    }
  },
  {
    "ts": null,
    "headline": "Assessing Baxter International (BAX) Valuation After Mixed Short And Long Term Shareholder Returns",
    "summary": "Why Baxter International (BAX) Is On Investors’ Radar Today Baxter International (BAX) has drawn interest after a recent stretch where its shares show mixed performance across different timeframes. This has prompted investors to reassess the company’s valuation, risk profile, and growth ambitions in healthcare products. See our latest analysis for Baxter International. At a share price of US$20.11, Baxter has seen a 6.1% 1 month share price return but a 12.3% 3 month share price decline. Its...",
    "url": "https://finnhub.io/api/news?id=43f60f72d7a7cb5b967dcb82f4790938908f6cccad5de1e8a14f3ed1a3455933",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768900093,
      "headline": "Assessing Baxter International (BAX) Valuation After Mixed Short And Long Term Shareholder Returns",
      "id": 138185108,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BAX",
      "source": "Yahoo",
      "summary": "Why Baxter International (BAX) Is On Investors’ Radar Today Baxter International (BAX) has drawn interest after a recent stretch where its shares show mixed performance across different timeframes. This has prompted investors to reassess the company’s valuation, risk profile, and growth ambitions in healthcare products. See our latest analysis for Baxter International. At a share price of US$20.11, Baxter has seen a 6.1% 1 month share price return but a 12.3% 3 month share price decline. Its...",
      "url": "https://finnhub.io/api/news?id=43f60f72d7a7cb5b967dcb82f4790938908f6cccad5de1e8a14f3ed1a3455933"
    }
  },
  {
    "ts": null,
    "headline": "How Recent Analyst Shifts Are Rewriting The Baxter International (BAX) Investment Story",
    "summary": "Baxter International’s latest valuation update reflects a slightly lower fair value estimate, trimmed from about US$23.80 to about US$23.13 per share, as analysts weigh mixed signals around guidance, execution and recovery potential. The modest adjustment in the model, alongside a small tweak to the discount rate and long run revenue growth assumption, captures how recent bullish and bearish research has converged toward a more balanced view of risk and opportunity already reflected in the...",
    "url": "https://finnhub.io/api/news?id=4b281b5a01864bb7036de867e69f75e818591a7cce8011b9cb497bb87f42692e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768896641,
      "headline": "How Recent Analyst Shifts Are Rewriting The Baxter International (BAX) Investment Story",
      "id": 138185109,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BAX",
      "source": "Yahoo",
      "summary": "Baxter International’s latest valuation update reflects a slightly lower fair value estimate, trimmed from about US$23.80 to about US$23.13 per share, as analysts weigh mixed signals around guidance, execution and recovery potential. The modest adjustment in the model, alongside a small tweak to the discount rate and long run revenue growth assumption, captures how recent bullish and bearish research has converged toward a more balanced view of risk and opportunity already reflected in the...",
      "url": "https://finnhub.io/api/news?id=4b281b5a01864bb7036de867e69f75e818591a7cce8011b9cb497bb87f42692e"
    }
  }
]